Skip to main content

Table 4 Univariable and multivariable analyses of factors associated with mortality for patients who were not on ART at start of TB treatment

From: HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town

 

PYRS

Deaths

Univariable

Multivariable

Characteristic

  

HR (95% CI)

P-value

aHR (95% CI)

P-value

Calendar year

 2009

5169

823

1

0.03

1

0.38

 2010

5163

733

0.89 (0.81–0.98)

< 0.001

1.05 (0.94–1.18)

0.66

 2011

4769

616

0.81 (0.73–0.90)

< 0.001

1.03 (0.91–1.16)

0.09

 2012

3943

512

0.82 (0.73–0.91)

< 0.001

1.12 (0.98–1.27)

0.55

 2013

3361

401

0.73 (0.65–0.83)

 

1.04 (0.91–1.21)

 

Age (per 10 years increase)

22,405

3085

1.34 (1.30–1.39)

< 0.001

1.38 (1.32–1.44)

< 0.001

Female gender

11,662

1528

1

0.004

1

0.004

Male gender

10,743

1557

1.11 (1.03–1.19)

 

0.89 (0.82–0.96)

 

Re-treatment TB

7142

1122

1

 

1

 

New TB

15,263

1963

0.76 (0.71–0.82)

< 0.001

0.67 (0.62–0.73)

< 0.001

PTB

18,083

2391

1

 

1

 

EPTB

4321

694

1.20 (1.11–1.31)

< 0.001

1.25 (1.14–1.38)

< 0.001

CD4 (per increase of 50 cells/mm3)

21,574

2807

0.85 (0.84–0.86)

< 0.001

0.82 (0.81–0.83)

< 0.001

Did not start ART

7037

1254

1

 

1

 

Started ART

13,145

1301

0.56 (0.52–0.61)

< 0.001

0.39 (0.35–0.42)

< 0.001

  1. PYRS person years, HR Hazard Ratio, aHR Adjusted Hazard Ratio, CI confidence interval, TB tuberculosis, PTB pulmonary tuberculosis, EPTB extra-pulmonary tuberculosis, ART antiretroviral therapy